FMI’s 3Q14 CC was more than two weeks ago (#msg-107883584), so I don’t think that’s what’s driving the share price now.
FMI is a thinly-traded stock, and the consequence is large daily movements in the share price for no particular reason. I don't have an explanation for the price action this week, specifically.
More so than the analysts’ reports, the general publicity surrounding the approval of ABBV/ENTA’s regimen will attract attention to ENTA, which remains a stock that doesn’t get much.
It depends on the label in its entirety. There are too many permutations to speculate about this with much confidence.